232 related articles for article (PubMed ID: 8770184)
1. Structural model of a synthetic Ca2+ channel with bound Ca2+ ions and dihydropyridine ligand.
Zhorov BS; Ananthanarayanan VS
Biophys J; 1996 Jan; 70(1):22-37. PubMed ID: 8770184
[TBL] [Abstract][Full Text] [Related]
2. Homology model of dihydropyridine receptor: implications for L-type Ca(2+) channel modulation by agonists and antagonists.
Zhorov BS; Folkman EV; Ananthanarayanan VS
Arch Biochem Biophys; 2001 Sep; 393(1):22-41. PubMed ID: 11516158
[TBL] [Abstract][Full Text] [Related]
3. Docking of verapamil in a synthetic Ca2+ channel: formation of a ternary complex involving Ca2+ ions.
Zhorov BS; Ananthanarayanan VS
Arch Biochem Biophys; 1997 May; 341(2):238-44. PubMed ID: 9169010
[TBL] [Abstract][Full Text] [Related]
4. Conserved Ca2+-antagonist-binding properties and putative folding structure of a recombinant high-affinity dihydropyridine-binding domain.
Huber I; Wappl E; Herzog A; Mitterdorfer J; Glossmann H; Langer T; Striessnig J
Biochem J; 2000 May; 347 Pt 3(Pt 3):829-36. PubMed ID: 10769189
[TBL] [Abstract][Full Text] [Related]
5. Characterizing the 1,4-dihydropyridines binding interactions in the L-type Ca2+ channel: model construction and docking calculations.
Cosconati S; Marinelli L; Lavecchia A; Novellino E
J Med Chem; 2007 Apr; 50(7):1504-13. PubMed ID: 17335186
[TBL] [Abstract][Full Text] [Related]
6. The beta subunit controls the gating and dihydropyridine sensitivity of the skeletal muscle Ca2+ channel.
Lory P; Varadi G; Schwartz A
Biophys J; 1992 Nov; 63(5):1421-4. PubMed ID: 1282375
[TBL] [Abstract][Full Text] [Related]
7. Glutamate substitution in repeat IV alters divalent and monovalent cation permeation in the heart Ca2+ channel.
Parent L; Gopalakrishnan M
Biophys J; 1995 Nov; 69(5):1801-13. PubMed ID: 8580323
[TBL] [Abstract][Full Text] [Related]
8. [Single channel analysis of Ca2+ channel-agonistic action of dihydropyridine derivatives: voltage-dependent effects of YC-170 and BAY K 8644].
Takeda Y
Hokkaido Igaku Zasshi; 1993 Jul; 68(4):557-69. PubMed ID: 7687975
[TBL] [Abstract][Full Text] [Related]
9. Receptor model for the molecular basis of tissue selectivity of 1, 4-dihydropyridine calcium channel drugs.
Langs DA; Strong PD; Triggle DJ
J Comput Aided Mol Des; 1990 Sep; 4(3):215-30. PubMed ID: 2177783
[TBL] [Abstract][Full Text] [Related]
10. Key roles of Phe1112 and Ser1115 in the pore-forming IIIS5-S6 linker of L-type Ca2+ channel alpha1C subunit (CaV 1.2) in binding of dihydropyridines and action of Ca2+ channel agonists.
Yamaguchi S; Zhorov BS; Yoshioka K; Nagao T; Ichijo H; Adachi-Akahane S
Mol Pharmacol; 2003 Aug; 64(2):235-48. PubMed ID: 12869628
[TBL] [Abstract][Full Text] [Related]
11. Mapping of dihydropyridine binding residues in a less sensitive invertebrate L-type calcium channel (LCa v 1).
Senatore A; Boone A; Lam S; Dawson TF; Zhorov B; Spafford JD
Channels (Austin); 2011; 5(2):173-87. PubMed ID: 21487241
[TBL] [Abstract][Full Text] [Related]
12. Competitive and cooperative effects of Bay K8644 on the L-type calcium channel current inhibition by calcium channel antagonists.
Zahradníková A; Minarovic I; Zahradník I
J Pharmacol Exp Ther; 2007 Aug; 322(2):638-45. PubMed ID: 17475903
[TBL] [Abstract][Full Text] [Related]
13. Effects of the novel water-soluble calcium antagonist (+/-)-3-(4-allyl-1-piperazinyl)-2,2-dimethylpropyl methyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate dihydrochloride on the responses of isolated canine arteries.
Kanda M; Shirahase H; Kurahashi K; Wada K; Nakamura S; Matsui H; Fukata F
Arzneimittelforschung; 1995 Aug; 45(8):831-5. PubMed ID: 7575741
[TBL] [Abstract][Full Text] [Related]
14. Design of a functional calcium channel protein: inferences about an ion channel-forming motif derived from the primary structure of voltage-gated calcium channels.
Grove A; Tomich JM; Iwamoto T; Montal M
Protein Sci; 1993 Nov; 2(11):1918-30. PubMed ID: 7505682
[TBL] [Abstract][Full Text] [Related]
15. Potassium depolarization elevates cytosolic free calcium concentration in rat anterior pituitary cells through 1,4-dihydropyridine-sensitive, omega-conotoxin-insensitive calcium channels.
Meier K; Knepel W; Schöfl C
Endocrinology; 1988 Jun; 122(6):2764-70. PubMed ID: 2453348
[TBL] [Abstract][Full Text] [Related]
16. Ca2+ channel modulation alters halothane-induced depression of ventricular myocytes.
Kanaya N; Matsumoto M; Kawana S; Tsuchida H; Kimura H; Miyamoto A; Ohshika H; Namiki A
Can J Anaesth; 1998 Jun; 45(6):584-91. PubMed ID: 9669017
[TBL] [Abstract][Full Text] [Related]
17. Nifedipine and tetrodotoxin delay the onset of methylmercury-induced increase in [Ca2+]i in NG108-15 cells.
Hare MF; Atchison WD
Toxicol Appl Pharmacol; 1995 Dec; 135(2):299-307. PubMed ID: 8545840
[TBL] [Abstract][Full Text] [Related]
18. Molecular Basis for Ligand Modulation of a Mammalian Voltage-Gated Ca
Zhao Y; Huang G; Wu J; Wu Q; Gao S; Yan Z; Lei J; Yan N
Cell; 2019 May; 177(6):1495-1506.e12. PubMed ID: 31150622
[TBL] [Abstract][Full Text] [Related]
19. Transfer of the high affinity dihydropyridine sensitivity from L-type To non-L-type calcium channel.
Ito H; Klugbauer N; Hofmann F
Mol Pharmacol; 1997 Oct; 52(4):735-40. PubMed ID: 9380037
[TBL] [Abstract][Full Text] [Related]
20. [Effects of Bay K8644 and nifedipine on L-type Ca2+ channels in hypothalamic neurons of rats].
Fu QJ; Zou F
Sheng Li Xue Bao; 2001 Oct; 53(5):339-43. PubMed ID: 11833415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
